Alison Galvani, PhD
Burnett and Stender Families Professor of Epidemiology (Microbial Diseases)Cards
About
Titles
Burnett and Stender Families Professor of Epidemiology (Microbial Diseases)
Affiliated Faculty, Yale Institute for Global Health; Director of the Center for Infectious Disease Modeling and Analysis (CIDMA)
Biography
Alison Galvani, Ph.D., is the founding director of the Yale Center for Infectious Disease Modeling and Analysis (CIDMA) and the Burnett and Stender Families Professor of Epidemiology at the Yale School of Public Health, Yale School of Medicine. She has applied her modelling and health economics skills to address myriad public health challenges, including HIV/AIDS, Zika, Ebola, influenza, and COVID-19. In 2015, Galvani became the youngest faculty member ever appointed to an endowed chair in the history of the Yale School of Medicine. She earned her Ph.D. and B.A. from the University of Oxford.
Appointments
Epidemiology of Microbial Diseases
ProfessorPrimary
Other Departments & Organizations
- Center for Infectious Disease Modeling and Analysis (CIDMA)
- Climate Change and Health
- Epidemiology of Microbial Diseases
- Epidemiology of Microbial Diseases (EMD)
- Global Health Studies
- Yale Institute for Global Health
- Yale School of Public Health
- Yale School of Public Health - NEW
- Yale Ventures
- YSPH Global Health Concentration
Education & Training
- PhD
- University of Oxford (2002)
Research
Overview
Professor Galvani's research focuses on integrating epidemiology and the evolutionary ecology or economics in order to generate predictions that could not be made by these disciplines alone. This interdisciplinary approach has widespread potential for answering evolutionary questions, explaining empirical observations and informing public health policy. Professor Galvani has applied modeling and cost-effectiveness analyses to improve national and international public health policies of influenza, TB and HPV, HIV, rotavirus and Ebola, among other diseases.
Medical Research Interests
Public Health Interests
Academic Achievements & Community Involvement
News & Links
Media
- We showed that canine rabies vaccination was both an epidemiologically effective and economically cost-effective approach to protect people from rabies transmission (Fitzpatrick et al 2014 Annals of Internal Medicine).
News
- November 01, 2024Source: CT Public Radio
Access to weight-loss injectables remains limited for most needy in the US, Yale study finds
- October 16, 2024
Expanding Access to Weight-Loss Drugs Could Save Thousands of Lives A Year, Study Finds
- April 22, 2024Source: Yale News
Study: Proposed changes to Medicare, Medicaid could cost thousands of lives
- March 25, 2024Source: Healio
Study: Annual COVID-19 vaccine campaign with second dose reduces disease burden, costs